Exodus Point Capital Management, LP Intellia Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 80,752 shares of NTLA stock, worth $1.87 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
80,752
Previous 31,436
156.88%
Holding current value
$1.87 Million
Previous $994,000
123.44%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding NTLA
# of Institutions
316Shares Held
89.3MCall Options Held
686KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$254 Million2.16% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$211 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$211 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$106 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$97.5 Million3.83% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.76B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...